3-year Grade 6 Laboratory Technician post just advertised in new microbiome lab at University of Dundee working with me.
I'd appreciate any retweets of this and would be very happy to be contacted about this opportunity!
dundee.t1cloud.com/T1Default/CiAn…

Just sharing this again for anyone interested in a 3-year microbiome lab technician post at University of Dundee...
Closing date is 21st June.
RTs welcome. Thanks! 🙂

We often talk about the necessity to move the needle in #IBD ; this new research feels like it has that promise.

Offering patients real, tangible hope is so crucial when it comes to the daily grind of living with chronic disease.

To James Lee and the team behind this work,

There's been amazing coverage of our new paper nature nature.com/articles/s4158… but I wanted to put together a walk-through (and make this accessible as possible). It's a bit long so get a cup of tea! The full version is open access so pls do have a read if you are interested...

Researchers at the Crick, working with @UCL and @ImperialCollegeLon, have discovered a new biological pathway that drives inflammatory bowel disease (IBD) and can be targeted using existing drugs.

crick.ac.uk/news-and-repor…

This work took 3⃣ years from conception to publication in @NatureRevGastro
‘A global consensus on definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice’
Essentials on this challenging #IBD treatment situation in a 🧵

1/11

Another big milestone for IBD-RESPONSE today!

Thanks to our amazing team of researchers at 42 UK centres and all the patients taking part!

With serial measures over 1 year IBD-RESPONSE is studying gut microbiome, human single cell transcriptome, metabolome, diet and detailed

New Comment - Buie and Margolis

Considerations for treating autistic individuals in gastroenterology clinics

Free w/registration 📄: thelancet.com/journals/langa…

#GITwitter

NIHR INSIGHT (North East & North Cumbria) are offering 30 fully-funded Research Masters studentships starting in September 2024.

For all information, registering for the Q&A Webinar and the online application form, go to:
newcastlehealthinnovation.org/nhip-academy/n…

We're excited to announce that we have recruited 550 participants to our study! 👏🎉🥳

Thank you to Newcastle Hospitals Chris Lamb , WGH Connect Charlie Lees Jonny Blackwell , Torbay and South Devon NHS Foundation Trust and OUH for recruiting the 5 most recent participants!

Another big milestone for IBD-RESPONSE today!

Thanks to our amazing team of researchers at 42 UK centres and all the patients taking part!

With serial measures over 1 year IBD-RESPONSE is studying gut microbiome, human single cell transcriptome, metabolome, diet and detailed

We're proud to be part of a new £13million partnership study to uncover what drives the onset and severity of conditions associated with inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis. 🔬🩺

#WeAreNCL #HealthResearch

ncl.ac.uk/press/articles…

📢 We're looking for people living with Crohn's or colitis in the UK to join our Open-IBD patient advisory group to help plan this exciting study!

Please help to promote this opportunity and consider applying at:

crohnsandcolitis.org.uk/get-involved/w…

🙏 Crohn's & Colitis UK!

Carl Anderson

📢 We're looking for people living with Crohn's or colitis in the UK to join our Open-IBD patient advisory group to help plan this exciting study!

Please help to promote this opportunity and consider applying at:

crohnsandcolitis.org.uk/get-involved/w…

🙏 Crohn's & Colitis UK!

Carl Anderson

Want to join a patient advisory group to help researchers at Newcastle University Chris Lamb with the design of their study 'Open-IBD' and to provide advice to the study team?

Find out more below 👇
crohnsandcolitis.org.uk/get-involved/w…

Looking forward to welcoming you all to Edinburgh for our joint hybrid event RCPEdin ACG SSG 🙏🏽to committee Ronald Hsu MD Paul Kwo David T. Rubin, MD prof Ghias un Nabi Tayyab John Paul Seenan 𝗗𝗿 𝗔𝗷𝗮𝘆 𝗠 𝗩𝗲𝗿𝗺𝗮 Dr Jennifer Murray. 🌍sessions on obesity, microbiome, IBD, hepatitis, AI, endoscopy.

Today is #WorldIBDDay2024 !

Inflammatory bowel disease (IBD) -- Crohn’s disease and ulcerative colitis -- affects 7 million people worldwide. It is characterized by chronic inflammation of the gastrointestinal tract, and often severely impact people’s lives and well-being. At

Thanks Helmsley Charitable Trust for amplifying and thanks for all you do to support research and care quality improvement for people living with Crohn’s! 🙏

Crohn’s and colitis are 🌍 conditions

Despite very welcome innovation & improvements in care there remain health inequalities between and within countries

🙏 to The Lancet for inviting patient-physician collaborative discussion on the central role of those with lived experience

On #WorldIBDday we want to give a BIG shoutout to all the amazing people living with IBD

Especially thank you to all patients who took part in the PROFILE trial including their family/supporters🙏

We are working closely with patients to translate findings to clinical practice🌎